Examkin

Question

Difficulty: MediumGynecologic Infections

A series of afebrile patients with stable vital signs present to the gynecology clinic evaluating for abnormal vaginal discharge and discomfort. Match each patient's specific clinical context and diagnostic findings with the most accurate diagnosis and its corresponding guideline-concordant management.

  • A 28-year-old woman at 14 weeks gestation reports a malodorous vaginal discharge. Pelvic exam shows thin, homogenous gray fluid with a pH of 5.5 and clue cells on microscopy.Bacterial vaginosis in pregnancy; manage with a standard course of oral metronidazole or clindamycin.
  • A 34-year-old woman reports her fourth episode this year of severe vulvar pruritus and thick, white, clumped discharge. Potassium hydroxide (KOH) preparation reveals branching pseudohyphae.Recurrent vulvovaginal candidiasis; manage with induction oral fluconazole followed by a 6-month maintenance regimen.
  • A 25-year-old woman has persistent frothy, yellow-green discharge and cervical petechiae despite recently completing metronidazole therapy. Her new male partner was not treated.Trichomoniasis with reinfection; manage with a repeat course of systemic metronidazole and mandatory concurrent partner treatment.
  • A 22-year-old woman with a copper intrauterine device (IUD) presents with mucopurulent cervical discharge and a friable cervix. Gram stain shows abundant polymorphonuclear leukocytes.Cervicitis; manage empirically with intramuscular ceftriaxone and oral doxycycline, while leaving the intrauterine device in place.

Answer

The correct matches pair the pregnant patient with bacterial vaginosis to standard metronidazole, the recurrent candidiasis patient to induction plus maintenance fluconazole, the reinfected trichomoniasis patient to repeat metronidazole with partner therapy, and the IUD patient with cervicitis to empiric broad-spectrum coverage while retaining the IUD.
Each correct pair links a classic presentation of a gynecologic infection with a specific modifying clinical context (pregnancy, recurrence, partner status, IUD presence) to its evidence-based, guideline-concordant therapeutic strategy.

Step-by-Step Solution

1
Analyze each patient vignette for distinct clinical contexts (pregnancy, recurrent episodes, treatment failure, or presence of an IUD).
The contexts alter standard management compared to uncomplicated, first-time presentations of these infections.
Gynecologic infections frequently present with complicating factors that dictate specific guideline adaptations.
2
Correlate the physical exam and microscopic findings to definitively diagnose the underlying infection.
Clue cells and pH 5.5 indicate bacterial vaginosis; pseudohyphae indicate candidiasis; motile protozoa and persistent symptoms without partner therapy indicate trichomoniasis reinfection; and mucopurulent discharge with a friable cervix indicates cervicitis.
Accurate identification of the pathogen is required before applying context-specific treatments.
3
Select the appropriate context-specific pharmacologic intervention and clinical action.
Pregnant BV patients receive standard oral therapy. Recurrent candidiasis requires 6 months of maintenance therapy. Trichomoniasis reinfection necessitates treating the untreated partner. IUDs can safely remain in place during the treatment of cervicitis.
Applying evidence-based adaptations prevents recurrences, ensures pregnancy safety, and avoids unnecessary device removal.

Key Concept

Management of gynecologic infections must be tailored to specific clinical contexts, including modifying regimens for recurrent vaginitis, ensuring partner treatment for STIs, and recognizing that an IUD does not require removal during initial treatment of cervicitis.
Rate this question

Topics

Gynecologic Infections

More questions from this topic